ASX - Delayed Quote AUD

Avecho Biotechnology Limited (AVE.AX)

Compare
0.0030 0.0000 (0.00%)
At close: December 13 at 11:02:55 AM GMT+11
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
473.5510
473.5510
1,206.1670
793.6000
384.6270
Cost of Revenue
517.3460
517.3460
336.1420
285.6630
143.7150
Gross Profit
-43.7950
-43.7950
870.0250
507.9370
240.9120
Operating Expense
4,724.0890
4,724.0890
3,856.9830
5,058.6460
3,647.9280
Operating Income
-4,767.8840
-4,767.8840
-2,986.9580
-4,550.7090
-3,407.0160
Net Non Operating Interest Income Expense
20.1600
20.1600
-2.0020
-9.4440
-5.1330
Other Income Expense
1,132.4680
1,132.4680
646.5690
1,144.0370
777.2960
Pretax Income
-3,436.5610
-3,436.5610
-2,342.3910
-3,416.1160
-2,634.8530
Net Income Common Stockholders
-3,436.5610
-3,436.5610
-2,342.3910
-3,416.1160
-2,634.8530
Basic EPS
-0.00
--
-0.00
-0.00
-0.00
Diluted EPS
-0.00
--
-0.00
-0.00
-0.00
Basic Average Shares
2,268,083.5940
--
1,837,784.8960
1,802,268.9200
1,591,077.9630
Diluted Average Shares
2,268,083.5940
--
1,837,784.8960
1,802,268.9200
1,591,077.9630
Net Income from Continuing & Discontinued Operation
-3,436.5610
-3,436.5610
-2,342.3910
-3,416.1160
-2,634.8530
Normalized Income
-3,436.5610
-3,436.5610
-2,342.3910
-3,416.1160
-2,634.4650
Interest Income
35.5160
35.5160
4.3470
0.5310
0.7920
Interest Expense
15.3560
15.3560
6.3490
9.9750
5.9250
Net Interest Income
20.1600
20.1600
-2.0020
-9.4440
-5.1330
EBIT
-3,421.2050
-3,421.2050
-2,336.0420
-3,406.1410
-2,628.9280
EBITDA
-3,242.5100
-3,242.5100
-2,105.6910
-2,977.5470
-2,092.2990
Reconciled Cost of Revenue
517.3460
517.3460
336.1420
285.6630
143.7150
Reconciled Depreciation
178.6950
178.6950
230.3510
428.5940
536.6290
Net Income from Continuing Operation Net Minority Interest
-3,436.5610
-3,436.5610
-2,342.3910
-3,416.1160
-2,634.8530
Total Unusual Items Excluding Goodwill
--
--
--
--
-0.3880
Total Unusual Items
--
--
--
--
-0.3880
Normalized EBITDA
-3,242.5100
-3,242.5100
-2,105.6910
-2,977.5470
-2,091.9110
12/31/2020 - 8/31/1993

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BIT.AX Biotron Limited
0.0170
-5.56%
 
BTC.AX BTC Health Limited
0.0660
-1.49%
 
ANR.AX Anatara Lifesciences Ltd
0.0470
+2.17%
 
1AI.AX Algorae Pharmaceuticals Limited
0.0080
0.00%
 
CHM.AX Chimeric Therapeutics Limited
0.0060
0.00%
 
ATX.AX Amplia Therapeutics Limited
0.0860
-1.15%
 
1AD.AX AdAlta Limited
0.0170
-5.56%
 
CMB.AX Cambium Bio Limited
0.4400
-18.52%
 
AGN.AX Argenica Therapeutics Limited
0.6850
-0.72%
 
NOX.AX Noxopharm Limited
0.1000
0.00%